The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Tumor cells can escape DNA‐damaging cisplatin through DNA endoreduplication and reversible polyploidy
Abstract
Cancer chemotherapy can induce tumor regression followed, in many cases, by relapse in the long‐term. Thus this study was performed to assess the determinants of such phenomenon using an in vivo cancer model and in vitro approaches. When animals bearing an established tumor are treated by cisplatin, the tumor initially undergoes a dramatic shrinkage and is characterized by giant tumor cells that do not proliferate but maintain DNA synthesis. After several weeks of latency, the tumor resumes its progression and consists of small proliferating cells. Similarly, when tumor cells are exposed in vitro to pharmacological concentrations of cisplatin, mitotic activity stops initially but cells maintain DNA duplication. This DNA endoreduplication generates giant polyploid cells that then initiate abortive mitoses and can die through mitotic catastrophe. However, many polyploid cells survive for weeks as non‐proliferating mono‐ or multi‐nucleated giant cells which acquire a senescence phenotype. Prolonged observation of these cells sheds light on the delayed emergence of a limited number of extensive colonies which originate from polyploid cells, as demonstrated by cell sorting analysis. Theses colonies are made of small diploid cells which differ from parental cells by stereotyped chromosomal aberrations and an increased resistance to cytotoxic drugs. These data suggest that a multistep pathway, including DNA endoreduplication, polyploidy, then depolyploidization and generation of clonogenic escape cells can account for tumor relapse after initial efficient chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
Self-citationA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
The role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
Edgar, B. A., & Orr-Weaver, T. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00334-8 · Cited by 846
From polyploidy to aneuploidy, genome instability and cancer
Storchova, Z., & Pellman, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 810
Characterization of clonogenic multiple myeloma cells
Matsui, W., Huff, C. A., Wang, Q., Malehorn, M. T., Barber, J., Tanhehco, Y., Smith, B. D., Civin, C. I., & Jones, R. J. (2004) · Blood · doi:10.1182/blood-2003-09-3064 · Cited by 789
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
(2002) · PubMed · Cited by 640
(1999) · PubMed · Cited by 546
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428
Eom, Y.-W., Kim, M. A., Park, S. S., Goo, M. J., Kwon, H. J., Sohn, S., Kim, W.-H., Yoon, G., & Choi, K. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208627 · Cited by 351
Costello, R. T., Mallet, F., Gaugler, B., Sainty, D., Arnoulet, C., Gastaut, J., & Olive, D. (2000) · PubMed · Cited by 287
Reles, A., Wen, W., Schmider, A., Gee, C., Runnebaum, I. B., Kilian, U., Jones, L. A., El‐Naggar, A. K., Minguillon, C., Schönborn, I., et al. (2001) · PubMed · Cited by 282
Neosis: A Novel Type of Cell Division in Cancer
Sundaram, M., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, R. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.663 · Cited by 207
Endomitosis of Human Megakaryocytes Are Due to Abortive Mitosis
Vitrat, N., Cohen-Solal, K., Pique, C., LeCouedic, J. P., Norol, F., Larsen, A. K., Katz, A., Vainchenker, W., & Debili, N. (1998) · Blood · doi:10.1182/blood.v91.10.3711 · Cited by 189
Arpino, G., Gutierrez, C., Weiss, H., Rimawi, M., Massarweh, S., Bharwani, L., De Placido, S., Osborne, C. K., & Schiff, R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk151 · Cited by 188
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 169
POLYPLOID GIANT CELLS PROVIDE A SURVIVAL MECHANISM FOR p53 MUTANT CELLS AFTER DNA DAMAGE
Illidge, T. M., Cragg, M. S., Fringes, B., Olive, P., & Erenpreisa, J. A. (2000) · Cell Biology International · doi:10.1006/cbir.2000.0557 · Cited by 169
Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents
Nitta, M., Kobayashi, O., Honda, S., Hirota, T., Kuninaka, S., Marumoto, T., Ushio, Y., & Saya, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207873 · Cited by 167
Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells.
Wang, L., Wong, S. C., Pan, J., Tsao, S. W., Fung, K., Kwong, D., Sham, J. S. T., & Nicholls, J. M. (1998) · PubMed · Cited by 154
Elmore, L. W., Di, X., Dumur, C., Holt, S. E., & Gewirtz, D. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1462 · Cited by 151
Population pharmacokinetics of total and unbound plasma cisplatin in adult patients
Urien, S., & Lokiec, F. M. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02082.x · Cited by 150
Segregation of genomes in polyploid tumour cells following mitotic catastrophe
Erenpreisa, J. A., Kalējs, M., Ianzini, F., Kosmacek, E. A., Mackey, M. C., EMZINSH, D., Cragg, M. S., Ivanov, A., & Illidge, T. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.10.008 · Cited by 137
Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen, J.-G., Yang, C.-P. H., Cammer, M., & Horwitz, S. B. (2003) · PubMed · Cited by 132
Andreassen, P. R., Lacroix, F., Lohez, O. D., & Margolis, R. L. (2001) · PubMed · Cited by 132
RELEASE OF MITOTIC DESCENDANTS BY GIANT CELLS FROM IRRADIATED BURKITT'S LYMPHOMA CELL LINES
Erenpreisa, J. A., Cragg, M. S., Fringes, B., Sharakhov, I. V., & Illidge, T. (2000) · Cell Biology International · doi:10.1006/cbir.2000.0558 · Cited by 125
Cancer: A matter of life cycle?
Erenpreisa, J. A., & Cragg, M. S. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.08.013 · Cited by 97
Lin, X., & Howell, S. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0491 · Cited by 89
Solari, F., Domenget, C., Gire, V., Woods, C., Lazarides, E., Rousset, B., & Jurdic, P. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.10.3233 · Cited by 55
Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni, W. C., Gervais, A. C., Egorin, M. J., Schellens, J. H. M., Hamburger, D. R., Delauter, B. J., Grim, A., Zuhowski, E. G., Joseph, E., Pluim, D., et al. (2002) · PubMed · Cited by 47
Cassinelli, G., Lanzi, C., Supino, R., Pratesi, G., Zuco, V., Laccabue, D., Cuccuru, G., Bombardelli, E., & Zunino, F. (2002) · PubMed · Cited by 36
Caspase independence of radio-induced cell death
Zhang, P., Castedo, M., Tao, Y., Violot, D., Métivier, D., Deutsch, É., Kroemer, G., & Bourhis, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209744 · Cited by 36
Self-citationPastor, N., Cantero, G., Campanella, C., & Cortés, F. (2005) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2004.12.006 · Cited by 14
Cited by
Endoreplication: polyploidy with purpose
Lee, H. O., Davidson, J. M., & Duronio, R. J. (2009) · Genes & Development · doi:10.1101/gad.1829209 · Cited by 590
Holtan, S. G., Creedon, D. J., Haluska, P., & Markovic, S. N. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60669-1 · Cited by 292
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Hubackova, S., Krejcikova, K., Bartek, J., & Hodny, Z. (2012) · Aging · doi:10.18632/aging.100520 · Cited by 272
Niu, N., Mercado-Uribe, I., & Liu, J. (2017) · Oncogene · doi:10.1038/onc.2017.72 · Cited by 265
Metadata
- Authors
- Puig, P., Guilly, M., Bouchot, A., Droin, N., Cathelin, D., Bouyer, F., Favier, L., Ghiringhelli, F., Kroemer, G., Solary, E., Martin, F., & Chauffert, B.
- Venue
- Cell Biology International
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 32
- Issue
- 9
- Pages
- 1031-1043
- ISSN
- 1065-6995 (ISSN-L)
- 1095-8355
- OpenAlex
- W2133632121
- Cited by
- 253
- References
- 39
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.